Mar. 20, 2024 |
|
Mar. 20, 2024 |
|
jRCT1031230719 |
Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM in ALS Patients |
|
Retrospective Study on the Safety and Therapeutic/Improvement Effects of Intravenous Administration of SHED-CM in ALS Patients |
Seta Yasuhiro |
||
Hitonowa Medical |
||
K-PLAZA 2F 1-7 Rokubancho, Chiyoda-ku, Tokyo |
||
+81-3-6272-8181 |
||
info@smartcl-medical.jp |
||
Sekine Midori |
||
Hitonowa Medical |
||
K-PLAZA 2F 1-7 Rokubancho, Chiyoda-ku, Tokyo |
||
+81-3-6272-8181 |
||
info@smartcl-medical.jp |
Recruiting |
Dec. 25, 2023 |
||
28 | ||
Observational |
||
single arm study |
||
open(masking not used) |
||
uncontrolled control |
||
single assignment |
||
treatment purpose |
||
1. patients who visited our clinic between January 1, 2022 and November 30, 2023 and have been diagnosed with ALS |
||
1. Patients who have a tracheostomy at the time of visit. |
||
16age old over | ||
90age old not | ||
Both |
||
amyotrophic lateral sclerosis (ALS) |
||
ALS |
||
8B60.0 |
||
Adverse Events |
||
1. check the amount and rate of change in each ALSFRS-R score and the total ALSFRS-R score |
Hitonowa Medical Seta Yasuhiro |
JSCSF Ethics Review Committee | |
Shimmakichobiru 6F 1-8-16 Yaesu, Chuo-ku, Tokyo, Tokyo | |
+81-3-5542-1597 |
|
mail@jscsf.net | |
Approval | |
Dec. 25, 2023 |
No |
|
無し | |
None |
none |